Arrhythmia Alliance News & Events

“The RAPID Study” NODE-301 Trial Part 2, Now Accepting Patients with PSVT for Nasal Spray Clinical Study

Arrhythmia Alliance has been made aware of the below study taking place

“The RAPID Study” NODE-301 Trial Part 2, Now Accepting Patients with PSVT for Nasal Spray Clinical Study

Eligible patients living with paroxysmal supraventricular tachycardia (PSVT) are invited to participate in a clinical study of an investigational new medication developed as a single use, self-administered nasal spray to terminate episodes of SVT. The RAPID Study (also called NODE-301 Part 2) is now accepting participants who have a history of SVT episodes lasting approximately 20 minutes or longer.

Patients who are interested, please call 1-833-213-5268 or visit rapidnode301clinicaltrial.com

Share

Send us your feedback

Patient Resources

To download our information resource and receive regular updates from Arrhythmia Alliance please enter your details below*:

No thanks

*Please note you can unsubscribe from our mailing list at any time

This link will take you to the site

Stay on this site